KemPharm, Inc. (ZVRA) Earnings
|
Expand Research on ZVRA
| Next EPS Date | 11/11/26 | EPS Growth Rate | -15.8% |
|---|---|---|---|
| Average EPS % Beat Rate | +282.8% | Revenue Growth Rate | +8.7% |
| Average % Move 1-Wk after EPS | +2.3% | Normal Earnings Time | After Close |
| Date | Qtr | EPS | Cons. | Surprise | Revs | Cons. | Gd. | 1-Week % | 1-Day % | Details | |
|---|---|---|---|---|---|---|---|---|---|---|---|
11/11/26  |
Q326 | N/A | $0.16 | N/A | N/A | $37.08M | N/A | N/A | N/A | ||
| 8/5/26 |
Q226 | $0.14 | $0.11 | +$0.03 | $39.7M | $34.17M | N/A |  | | Details | |
| 5/6/26 | Q425 | $0.60 | $0.07 | +$0.53 | $36.2M | $31.96M | N/A | | | Details | |
| 3/9/26 | Q325 | $0.19 | $0.05 | +$0.14 | $34.1M | $28.05M | N/A | | | Details | |
| 11/5/25 | Q225 | -$0.01 | -$0.03 | +$0.02 | $26.1M | $26.64M | N/A | | | Details | |
| 8/12/25 | Q125 | -$0.06 | $2.19 | -$2.25 | $25.9M | $22.49M | N/A | | | Details | |
| 5/13/25 |
Q125 | N/A | -$0.24 | N/A | $20.4M | $16.02M | N/A | N/A | N/A | ||
| 2/28/25 |
Q424 | N/A | -$0.40 | N/A | N/A | $8.52M | N/A | N/A | N/A |
